TREML4 and myocardial ischemia: The analysis of the whole genomic expression in the peripheral blood cell model showed that TREML4 was upregulated in the early stage of the acute coronary syndrome [149], which indicated that TREML4 might be used as a biomarker in the early stage of ACS and monitor the recovery of early myocardial ischemia [150].